Literature DB >> 19459077

The Trail Making Test and its neurobehavioral components.

Esther L Misdraji1, Carlton S Gass.   

Abstract

UNLABELLED: This study investigates the neurobehavioral components involved in Trail Making Test (TMT; Parts A and B) performance and their relation to MMPI-2 measures of anxiety and depression. Consecutive patients (N = 192) referred for a comprehensive neuropsychological evaluation at a U.S. Department of Veterans Affairs (VA) Medical Center comprised the sample.
RESULTS: graphomotor speed and mental shifting were significantly associated with Wechsler Adult Intelligence Scale-Third Edition (WAIS-III) indexes, whereas visual scanning efficiency was not. Graphomotor speed accounted for a substantially greater portion of the variance in TMT performance within impaired than within normal groups. Levels of anxiety and depressive symptoms were unrelated to TMT performance. Implications and directions for future research are discussed.

Entities:  

Mesh:

Year:  2009        PMID: 19459077     DOI: 10.1080/13803390902881942

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  20 in total

1.  Clinical expression of LRRK2 G2019S mutations in the elderly.

Authors:  Marta San Luciano; Richard B Lipton; Cuiling Wang; Mindy Katz; Molly E Zimmerman; Amy E Sanders; Laurie J Ozelius; Susan B Bressman; Rachel Saunders-Pullman
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

2.  Influence of vascular risk factors on executive function among an age-homogeneous elderly cohort.

Authors:  Nazanin Sédille-Mostafaie; S Zehetmayer; W Krampla; W Krugluger; P Fischer
Journal:  J Neural Transm (Vienna)       Date:  2015-03-11       Impact factor: 3.575

3.  Exploring the "Obesity Paradox" as a Correlate of Cognitive and Physical Function in Community-dwelling Black and White Older Adults.

Authors:  Jeannine S Skinner; Willie Mae Abel; Katryna McCoy; Consuelo H Wilkins
Journal:  Ethn Dis       Date:  2017-12-07       Impact factor: 1.847

4.  Differences in white matter structure and cortical thickness between patients with traumatic and idiopathic chronic neck pain: Associations with cognition and pain modulation?

Authors:  I Coppieters; R De Pauw; K Caeyenberghs; D Lenoir; K DeBlaere; E Genbrugge; M Meeus; B Cagnie
Journal:  Hum Brain Mapp       Date:  2018-01-11       Impact factor: 5.038

5.  What cognitive abilities are involved in trail-making performance?

Authors:  Timothy A Salthouse
Journal:  Intelligence       Date:  2011-07

6.  The Trail Making Test in prodromal Huntington disease: contributions of disease progression to test performance.

Authors:  Justin J F O'Rourke; Leigh J Beglinger; Megan M Smith; James Mills; David J Moser; Kelly C Rowe; Douglas R Langbehn; Kevin Duff; Julie C Stout; Deborah L Harrington; Noelle Carlozzi; Jane S Paulsen
Journal:  J Clin Exp Neuropsychol       Date:  2011-02-07       Impact factor: 2.475

7.  Cognitive and motor functioning in elderly glucocerebrosidase mutation carriers.

Authors:  Eileen E Moran; Cuiling Wang; Mindy Katz; Laurie Ozelius; Alison Schwartz; Jelena Pavlovic; Roberto A Ortega; Richard B Lipton; Molly E Zimmerman; Rachel Saunders-Pullman
Journal:  Neurobiol Aging       Date:  2017-06-24       Impact factor: 4.673

8.  Quantitative and qualitative features of executive dysfunction in frontotemporal and Alzheimer's dementia.

Authors:  Andrew M Kiselica; Jared F Benge
Journal:  Appl Neuropsychol Adult       Date:  2019-08-19       Impact factor: 2.248

9.  How do we measure attention? Using factor analysis to establish construct validity of neuropsychological tests.

Authors:  Melissa Treviño; Xiaoshu Zhu; Yi Yi Lu; Luke S Scheuer; Eliza Passell; Grace C Huang; Laura T Germine; Todd S Horowitz
Journal:  Cogn Res Princ Implic       Date:  2021-07-22

10.  Niacin Enhancement for Parkinson's Disease: An Effectiveness Trial.

Authors:  Raymond Chong; Chandramohan Wakade; Marissa Seamon; Banabihari Giri; John Morgan; Sharad Purohit
Journal:  Front Aging Neurosci       Date:  2021-06-17       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.